GlassScriptPhysician profile
Elizabeth Mccarthy
NPI 1982068128
$2,826.56
in general payments reported to CMS, 2019-2025
12 companies · $88.16 in 2025
The $88.16 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $143 · 2020: $88.34 · 2021: $1,026 · 2022: $438 · 2023: $744 · 2024: $299 · 2025: $88.16.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $834 · Travel and Lodging: $298.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $833.74 |
| Travel and Lodging | $297.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,918.57 | 2021-2025 | Da Vinci Surgical System |
| Medtronic, INC. | $316.88 | 2021-2023 | Ligasure |
| Edwards Lifesciences Corporation | $199.93 | 2019-2020 | |
| Virtual Incision Corporation | $140.00 | 2024 | Mira |
| Ethicon US, LLC | $93.48 | 2022 | |
| Davol INC. | $55.09 | 2023 | Phasix Mesh |
| Integra Lifesciences Corporation | $26.50 | 2022 | |
| La Jolla Pharmaceutical Company | $18.40 | 2019 | |
| Distalmotion US | $16.80 | 2025 | Dexter L6 Robot |
| Novo Nordisk INC | $14.38 | 2022 | |
| Intra-Sana Laboratories | $13.28 | 2023 | Glycate, Reltone 200 Mg, Reltone 400 Mg |
| E.R. Squibb & Sons, L.L.C. | $13.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Mccarthy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.